Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Sharma

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 16, 2013
Oesophageal Chemoradiotherapy in the UK--current practice and future directionsS Gwynne, S Falk, S Gollins, et al.
Oncogene|October 20, 2009
Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapyJ Yang, J Parsons, N H Nicolay, et al.
Radiation Oncology (London, England)|March 13, 2024
FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approachE C Daugherty, Y Zhang, Z Xiao, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 10, 2018
Analysis of a National Programme for Selective Internal Radiation Therapy for Colorectal Cancer Liver MetastasesJ White, G Carolan-Rees, M Dale, et al.
Scientific Reports|May 10, 2018
Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinomaT P MacGregor, R Carter, R S Gillies, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 16, 2013
Oesophageal Chemoradiotherapy in the UK--current practice and future directionsS Gwynne, S Falk, S Gollins, et al.
Oncogene|October 20, 2009
Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapyJ Yang, J Parsons, N H Nicolay, et al.
Radiation Oncology (London, England)|March 13, 2024
FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approachE C Daugherty, Y Zhang, Z Xiao, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 10, 2018
Analysis of a National Programme for Selective Internal Radiation Therapy for Colorectal Cancer Liver MetastasesJ White, G Carolan-Rees, M Dale, et al.
Scientific Reports|May 10, 2018
Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinomaT P MacGregor, R Carter, R S Gillies, et al.
Pageof 8